Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biomarin Pharmaceutical Inc (BMRN)  
$88.63 1.44 (1.6%) as of 4:30 Fri 4/19


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 188,370,000
Market Cap: 16.70(B)
Last Volume: 1,778,607 Avg Vol: 1,398,026
52 Week Range: $76.22 - $99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  811
Guru Rank Value     : 0.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 3,625
Total Buy Value $0 $0 $0 $314,469
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 139,229 182,993 316,353 638,922
Total Sell Value $12,316,080 $16,513,389 $28,948,007 $60,375,372
Total People Sold 5 5 6 8
Total Sell Transactions 11 15 24 57
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 1303
  Page 18 of 53  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Wood Mark VP, Human Resources   •       –      –    2012-10-22 4 AS $41.86 $111,554 D/D (2,665) 32,364     -
   Wood Mark VP, Human Resources   •       –      –    2012-10-22 4 OE $14.39 $54,394 D/D 2,665 35,029     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2012-10-19 4 AS $42.72 $85,440 D/D (2,000) 175,691     -
   Baffi Robert EVP, Technical Operations   •       –      –    2012-10-16 4 AS $43.00 $860,000 D/D (20,000) 100,413     -
   Baffi Robert EVP, Technical Operations   •       –      –    2012-10-16 4 OE $17.33 $346,600 D/D 20,000 120,413     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2012-10-12 4 AS $41.32 $123,969 D/D (3,000) 177,691     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2012-10-12 4 OE $9.86 $29,580 D/D 3,000 180,691     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2012-10-01 4 AS $39.75 $198,760 D/D (5,000) 52,277     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2012-10-01 4 OE $11.05 $55,250 D/D 5,000 57,277     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2012-09-28 4 AS $40.20 $160,804 D/D (4,000) 177,691     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2012-09-28 4 OE $9.86 $39,440 D/D 4,000 181,691     -
   Wood Mark VP, Human Resources   •       –      –    2012-09-24 4 AS $40.48 $107,878 D/D (2,665) 32,364     -
   Wood Mark VP, Human Resources   •       –      –    2012-09-24 4 OE $14.39 $54,394 D/D 2,665 35,029     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2012-09-14 4 S $37.91 $151,628 D/D (4,000) 177,691     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2012-09-14 4 OE $9.86 $39,440 D/D 4,000 181,691     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2012-09-10 4 AS $38.62 $38,620 D/D (1,000) 177,691     -
   Ajer Jeffrey Robert SVP, Chief Commercial OfOffice   •       –      –    2012-09-05 3 IO $0.00 $0 D/D 0 10,570     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2012-09-04 4 AS $37.76 $188,791 D/D (5,000) 52,277     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2012-09-04 4 OE $11.05 $55,250 D/D 5,000 57,277     -
   Wood Mark VP, Human Resources   •       –      –    2012-08-22 4 AS $37.90 $101,089 D/D (2,665) 32,364     -
   Wood Mark VP, Human Resources   •       –      –    2012-08-22 4 OE $14.39 $54,394 D/D 2,665 34,217     -
   Lewis Alan Director   –       •      –    2012-08-06 4 S $37.57 $1,502,756 D/D (40,000) 15,900     -
   Lewis Alan Director   –       •      –    2012-08-06 4 OE $14.21 $426,300 D/D 30,000 55,900     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2012-08-01 4 AS $38.63 $193,145 D/D (5,000) 52,277     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2012-08-01 4 OE $11.05 $55,250 D/D 5,000 57,277     -
  1303 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 18 of 53
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us